CIK: 0001668029
Total reported value
$97.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Abg Acquisition CORP I | Stock-Other | 55.52% | — | — | |
| 2 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 34.92% | — | -52.04% | |
| 3 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 8.81% | — | — | |
| 4 | ✓ | Diffusion Pharmaceuticals In | Stock-Other | 0.75% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Abg Acquisition CORP I | +42.6% | — | Unchanged |
| 2 | AGLEUSD | Aeglea Biotherapeutics INC | +6.5% | — | Unchanged |
| 3 | ✓ | Diffusion Pharmaceuticals In | +0.5% | — | Unchanged |
| 4 | AVIR | Atea Pharmaceuticals INC | -13.4% | -52.04% | Trim |
| 5 | LUNG | Pulmonx CORP | — | EXIT | Sold out |